Pharmaceutical

Alumis Strengthens Leadership Team with Key Appointments

Jack Danilkowicz appointed as Chief Commercial Officer; bringing extensive experience successfully planning and executing commercial strategies at global biopharmaceutical companies Sara…

11 months ago

Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference

NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced…

11 months ago

Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC

- PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities…

11 months ago

Invitation to Cosmo’s Unaudited Full Year 2024 Financial Results Webcast on 6 March 2025

Dublin, Ireland--(Newsfile Corp. - January 28, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN: C43) (“Cosmo”) announced today that it will…

11 months ago

Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health

Funding expands manufacturing readiness for Valley fever vaccineThis follows Anivive's $33MM NIAID contract for fungal vaccinesIn total, Anivive has secured…

11 months ago

Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement

Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced…

11 months ago

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

TOKYO, Jan. 27, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments,…

11 months ago

MediSpend Expands Its Footprint in Governance, Risk and Compliance Solutions with Acquisition of Real Life Sciences

PORTSMOUTH, N.H., Jan. 27, 2025 /PRNewswire/ -- MediSpend, a global technology company providing best-in-class solutions for the life sciences industry,…

11 months ago

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated…

11 months ago

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for…

11 months ago